Accelmed Partners II L.P.
CIK 1807256 · View on SEC EDGAR ↗
Insider
First SEC filing: April 20, 2021 · Latest: April 20, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 2 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
2 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 22, 2022 | NPCE | P | 62,398 | $1.50 | $93,597 | 4,432,948 Direct | +1.43% | Acquired | 825.3% (price as of 2026-08-21) |
| Nov. 21, 2022 | NPCE | P | 327,893 | $1.50 | $491,840 | 4,370,550 Direct | +8.11% | Acquired | 825.3% (price as of 2026-08-21) |
| April 21, 2021 | NPCE | P | 588,235 | $17.00 | $9,999,995 | 588,235 Direct | — | Acquired | -18.4% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 26, 2021 | NPCE | Series B' Preferred Stock | Common Stock (3,454,422) | $0.00 | — | 3,454,422 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 20, 2021 | NPCE | Series B' Preferred Stock→ Common Stock (3,454,422) | 3,454,422 | Direct |